Upcoming Modifications to UM Guidelines BlueCross BlueShield of Tennessee

Guidelines to be effective December 1, 2026:

Ambulatory Care (AC):

• Cognitive Communication Disorders Rehabilitation

Home Care (HC):

• Hyperemesis Gravidarum

Guidelines to be effective December 31, 2026:

Ambulatory Care (AC):

• Ashkenazi Jewish Genetic Carrier Panel
• Autosomal Recessive and X-Linked Disease Carrier Screening - Gene Panel Testing
• Multiple Cancers, Including Cancer Syndromes (Hereditary) - Gene Panel
• Myelodysplastic Syndromes (Somatic) - Gene Panels
• Noninvasive Prenatal Testing (Cell-Free Fetal DNA)
• Y Chromosome Microdeletion Analysis

Behavioral Health (BH):

• Intensive Care Coordination (ICC): Intensive Outpatient Program - For BlueCare Use Only

To view all Guidelines modified by BlueCross BlueShield of Tennessee - http://www.bcbst.com/providers/UM_Guidelines/.